Oric Pharmaceuticals, Inc. (ORIC): Total Assets
$408.89M
As of 2025-12-31
$404.69M
As of 2026-06-30
+18.3%
3-year compound annual growth
+6.5%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $408.89M | +49.2% | 2026-02-23, Balance as of period end |
| 2024-12-31 | $274.14M | +8.8% | 2026-02-23, Balance as of period end |
| 2023-12-31 | $252.01M | +2.0% | 2025-02-18, Balance as of period end |
| 2022-12-31 | $247.18M | -17.2% | 2024-03-11, Balance as of period end |
| 2021-12-31 | $298.64M | -0.1% | 2023-03-16, Balance as of period end |
| 2020-12-31 | $299.00M | +217.8% | 2022-03-21, Balance as of period end |
| 2019-12-31 | $94.09M | n/a | 2021-03-23, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Oric Pharmaceuticals, Inc. (ORIC) | 2025-12-31 | $408.89M | +49.2% |
| Alumis Inc. (ALMS) | 2025-12-31 | $411.94M | +20.8% |
| Nkarta, Inc. (NKTX) | 2025-12-31 | $404.21M | -19.4% |
| Stoke Therapeutics, Inc. (STOK) | 2025-12-31 | $418.43M | +54.1% |
| Harrow, Inc. (HROW) | 2025-12-31 | $399.48M | +2.7% |
| Tango Therapeutics, Inc. (TNGX) | 2025-12-31 | $398.69M | +26.0% |
| Ironwood Pharmaceuticals Inc (IRWD) | 2025-12-31 | $396.90M | +13.1% |
| Erasca, Inc. (ERAS) | 2025-12-31 | $396.15M | -21.2% |
| MoonLake Immunotherapeutics (MLTX) | 2025-12-31 | $424.43M | -11.2% |
Compare ORIC, ALMS, NKTX, STOK side by side · Screen every company in Pharmaceutical Preparations ↗